CCM
Callodine Capital Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23M | Buy |
598,519
+28,519
| +5% | +$1.1M | 2.38% | 16 |
|
|
2025
Q1 | $22.1M | Sell |
570,000
-130,000
| -19% | -$5.04M | 3.67% | 11 |
|
|
2024
Q4 | $23.7M | Buy |
700,000
+95,000
| +16% | +$3.21M | 4.89% | 5 |
|
|
2024
Q3 | $24.7M | Buy |
605,000
+65,000
| +12% | +$2.66M | 5.16% | 6 |
|
|
2024
Q2 | $20.8M | Buy |
540,000
+140,000
| +35% | +$5.39M | 4.85% | 5 |
|
|
2024
Q1 | $17.1M | Sell |
400,000
-50,000
| -11% | -$2.14M | 4.15% | 10 |
|
|
2023
Q4 | $16.7M | Sell |
450,000
-25,000
| -5% | -$927K | 4.39% | 7 |
|
|
2023
Q3 | $17.2M | Buy |
475,000
+25,000
| +6% | +$906K | 4.8% | 6 |
|
|
2023
Q2 | $16M | Hold |
450,000
| – | – | 4.61% | 8 |
|
|
2023
Q1 | $16M | Buy |
450,000
+240,000
| +114% | +$8.54M | 4.72% | 9 |
|
|
2022
Q4 | $7.38M | Buy |
+210,000
| New | +$7.38M | 2.2% | 17 |
|